Benitec Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BNTC and other ETFs, options, and stocks.About BNTC
Benitec Biopharma, Inc. is a development-stage biotechnology company, which engages in the advancement of novel genetic medicines. The firm's proprietary platforms include DNA-directed RNA interference, or ddRNAi, combines RNA interference, or RNAi, with gene therapy to create medicines that facilitates sustained silencing of disease-causing genes following a single administration.
CEOJerel A. Banks
CEOJerel A. Banks
Employees19
Employees19
HeadquartersHayward, California
HeadquartersHayward, California
Founded1995
Founded1995
Employees19
Employees19
BNTC Key Statistics
Market cap399.80M
Market cap399.80M
Price-Earnings ratio-12.42
Price-Earnings ratio-12.42
Dividend yield—
Dividend yield—
Average volume99.02K
Average volume99.02K
High today$15.86
High today$15.86
Low today$15.01
Low today$15.01
Open price$15.86
Open price$15.86
Volume7.11K
Volume7.11K
52 Week high$17.15
52 Week high$17.15
52 Week low$9.10
52 Week low$9.10
Stock Snapshot
Benitec Biopharma(BNTC) stock is priced at $15.23, giving the company a market capitalization of 399.8M. It carries a P/E multiple of -12.42.
On 2025-11-05, Benitec Biopharma(BNTC) stock traded between a low of $15.01 and a high of $15.86. Shares are currently priced at $15.23, which is +1.5% above the low and -4.0% below the high.
Benitec Biopharma(BNTC) shares are trading with a volume of 7.11K, against a daily average of 99.02K.
During the past year, Benitec Biopharma(BNTC) stock moved between $9.10 at its lowest and $17.15 at its peak.
During the past year, Benitec Biopharma(BNTC) stock moved between $9.10 at its lowest and $17.15 at its peak.
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own BNTC. This list is generated using Robinhood data, and it’s not a recommendation.